Note: the documents on this web site are PDF files. If you do not have a PDF reader, you can download one now.

Product name Product type Date released
Expand Nepiten CMI 20 Oct 2025
 
Do not use if you have ever had an allergic reaction to [medicine] or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use Nepiten? in the full CMI.
read more
Expand Nepiten PI 17 Oct 2025
 
Expand Sitagliptin/Metformin XR Mylan CMI 16 Oct 2025
 
Do not use if you have ever had an allergic reaction to SITAGLIPTIN/METFORMIN XR MYLAN or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I take SITAGLIPTIN/METFORMIN XR MYLAN? in the full CMI.
read more
Expand Sitagliptin/Metformin XR Mylan PI 15 Oct 2025
 
Expand DBL Sodium Nitroprusside CMI 13 Oct 2025
 
You will not be given DBL Sodium Nitroprusside Concentrated Injection if you have ever had an allergic reaction to sodium nitroprusside or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any heart problems or any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand DBL Sodium Nitroprusside PI 09 Oct 2025
 
Expand Comirnaty LP.8.1 CMI 08 Oct 2025
 
You should not be given COMIRNATY LP.8.1 if you have had an allergic reaction to any of the ingredients in the vaccine. See list at the end of the CMI. Check with your doctor if you have had: a severe allergic reaction or breathing problems after any other vaccine or after being given any other COMIRNATY COVID-19 vaccine in the past; fainted following any needle injection; a severe illness or infection with high fever; a weakened immune system or are on a medicine that affects your immune system; a bleeding disorder, bruise easily or are on a blood thinning medicine. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. COMIRNATY LP.8.1 should not be given to infants under 6 months of age. For more information, see Section 2. What should I know before I am given COMIRNATY LP.8.1? in the full CMI.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Finasteride Viatris 1 CMI 08 Oct 2025
 
Finasteride Viatris 1 is for use by men only.
Finasteride Viatris 1 is used to treat men with male pattern hair loss to increase hair growth on the scalp and to prevent further hair loss.
Male pattern hair loss (also known as androgenetic alopecia) is a common condition in which men experience thinning of the hair on the scalp.
This often results in a receding hair line and/or balding on the top of the head. These changes typically start to occur in some men in their 20s and become more common with age.
Once hair loss has occurred over a long period of time, the hair may be permanently lost.
Male pattern hair loss is thought to be caused by a combination of family history (heredity) and production of a particular male hormone, called dihydrotestosterone (DHT). Men with male pattern hair loss have more DHT in the balding part of their scalp than in other parts, resulting in increased hair loss.

How Finasteride Viatris 1 works

Finasteride Viatris 1 specifically lowers the levels of DHT in the scalp, thus helping to reverse the balding process.
Finasteride Viatris 1 does not affect hair on other parts of the body.
Men with mild to moderate, but not complete, hair loss can expect to benefit from the use of Finasteride Viatris 1.
In women who were studied, Finasteride Viatris 1 was not effective in the treatment of hair loss (androgenetic alopecia).
There should be no need to change your usual hair care routine (for example, shampooing or haircuts) because you are taking Finasteride Viatris 1.
Finasteride Viatris 1 is not addictive.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Finasteride Viatris 5 CMI 08 Oct 2025
 
Finasteride Viatris 5 is for use by men only.
Finasteride Viatris 5 is used to treat a medical condition in men called benign prostatic hyperplasia or BPH. BPH is a condition where your prostate gland (which is near your bladder) has become bigger making it more difficult for you to pass urine.
This can lead to symptoms such as:
Weak or interrupted stream of urine.
Feeling that you cannot empty your bladder completely.
A delay before you start to pass urine.
Needing to pass urine often, especially at night.
Feeling that you must pass urine right away.
BPH occurs only in men and is common over the age of 50 years. In some men, BPH can lead to serious problems, including urinary tract infections and the sudden inability to pass urine at all. BPH can also lead to the need for surgery such as procedures to improve the flow of urine.
The prostate gland takes years to grow. Therefore, the symptoms of BPH take a long time to develop. Finasteride Viatris 5 works by slowly reducing the size of your prostate gland. This may lead to gradual improvement in your urine flow and other symptoms over several months. Finasteride Viatris 5 also helps reduce the risk of developing a sudden inability to pass urine (acute urinary retention) and the need for surgery. This may happen whether or not you notice any improvement or change in your symptoms.
Your doctor may have prescribed Finasteride Viatris 5 for another reason. Ask your doctor if you have any questions about why Finasteride Viatris 5 has been prescribed for you.
Finasteride Viatris 5 is not addictive.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Ondansetron ODT VTRS CMI 08 Oct 2025
 
Do not use if you have ever had an allergic reaction to ONDANSETRON ODT VTRS or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use ONDANSETRON ODT VTRS? in the full CMI.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Ondansetron VTRS CMI 08 Oct 2025
 
Do not use if you have ever had an allergic reaction to ondansetron or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use ONDANSETRON VTRS? in the full CMI.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand DBL Naloxone Hydrochloride CMI 03 Oct 2025
 
Do not start treatment if you have ever had an allergic reaction to naloxone or any of the ingredients listed at the end of this CMI.
Talk to your doctor if you have an addiction to, or regularly use opioids (including babies of mothers who fall into this category); have heart, lung, kidney or liver disease, or any other medical conditions; take any other medicines; or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before treatment with DBL Naloxone Hydrochloride? in the full CMI.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand DBL Naloxone Hydrochloride PI 01 Oct 2025
 
Expand Ondansetron VTRS PI 01 Oct 2025
 
Expand Ondansetron ODT VTRS PI 01 Oct 2025
 
Expand Finasteride Viatris 1 PI 01 Oct 2025
 
Expand Diaformin Alphapharm XR CMI 29 Sep 2025
 
Do not use if you have ever had an allergic reaction to DIAFORMIN ALPHAPHARM XR or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use DIAFORMIN ALPHAPHARM XR? in the full CMI.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Diaformin Alphapharm XR PI 25 Sep 2025
 
Expand Abiraterone Viatris CMI 24 Sep 2025
 
Do not use if you have ever had an allergic reaction to ABIRATERONE VIATRIS or any of the ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.
For more information, see Section 2. What should I know before I use ABIRATERONE VIATRIS? in the full CMI.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Abiraterone Viatris PI 22 Sep 2025